Literature DB >> 17373700

Association studies of 23 positional/functional candidate genes on chromosome 10 in late-onset Alzheimer's disease.

A R Morgan1, D Turic, L Jehu, G Hamilton, P Hollingworth, V Moskvina, L Jones, S Lovestone, C Brayne, D C Rubinsztein, B Lawlor, M Gill, M C O'Donovan, M J Owen, J Williams.   

Abstract

Late-onset Alzheimer's disease (LOAD) is a common neurodegenerative disorder, with a complex etiology. APOE is the only confirmed susceptibility gene for LOAD. Others remain yet to be found. Evidence from linkage studies suggests that a gene (or genes) conferring susceptibility for LOAD resides on chromosome 10. We studied 23 positional/functional candidate genes from our linkage region on chromosome 10 (APBB1IP, ALOX5, AD037, SLC18A3, DKK1, ZWINT, ANK3, UBE2D1, CDC2, SIRT1, JDP1, NET7, SUPV3L1, NEN3, SAR1, SGPL1, SEC24C, CAMK2G, PP3CB, SNCG, CH25H, PLCE1, ANXV111) in the MRC genetic resource for LOAD. These candidates were screened for sequence polymorphisms in a sample of 14 LOAD subjects and detected polymorphisms tested for association with LOAD in a three-stage design involving two stages of genotyping pooled DNA samples followed by a third stage in which markers showing evidence for association in the first stages were subjected to individual genotyping. One hundred and twenty polymorphisms were identified and tested in stage 1 (4 case + 4 control pools totaling 366 case and 366 control individuals). Single nucleotide polymorphisms (SNPs) showing evidence of association with LOAD were then studied in stage 2 (8 case + 4 control pools totaling 1,001 case and 1,001 control individuals). Five SNPs, in four genes, showed evidence for association (P < 0.1) at stage 2 and were individually genotyped in the complete dataset, comprising 1,160 LOAD cases and 1,389 normal controls. Two SNPs in SGPL1 demonstrated marginal evidence of association, with uncorrected P values of 0.042 and 0.056, suggesting that variation in SGPL1 may confer susceptibility to LOAD. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373700     DOI: 10.1002/ajmg.b.30509

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  17 in total

1.  Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease.

Authors:  J S K Kauwe; S Bertelsen; K Mayo; C Cruchaga; R Abraham; P Hollingworth; D Harold; M J Owen; J Williams; S Lovestone; J C Morris; A M Goate
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-06-05       Impact factor: 3.568

Review 2.  Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells.

Authors:  Xing Liu; Qing-Hai Zhang; Guang-Hui Yi
Journal:  Mol Cell Biochem       Date:  2011-11-24       Impact factor: 3.396

3.  The molecular genetics of sirtuins: association with human longevity and age-related diseases.

Authors:  Letizia Polito; Patrick G Kehoe; Gianluigi Forloni; Diego Albani
Journal:  Int J Mol Epidemiol Genet       Date:  2010-06-20

Review 4.  S1P metabolism in cancer and other pathological conditions.

Authors:  Weng In Leong; Julie D Saba
Journal:  Biochimie       Date:  2010-02-16       Impact factor: 4.079

5.  SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease.

Authors:  Carlos Cruchaga; John S K Kauwe; Kevin Mayo; Noah Spiegel; Sarah Bertelsen; Petra Nowotny; Aarti R Shah; Richard Abraham; Paul Hollingworth; Denise Harold; Michael M Owen; Julie Williams; Simon Lovestone; Elaine R Peskind; Ge Li; James B Leverenz; Douglas Galasko; John C Morris; Anne M Fagan; David M Holtzman; Alison M Goate
Journal:  PLoS Genet       Date:  2010-09-16       Impact factor: 5.917

Review 6.  Lyase to live by: sphingosine phosphate lyase as a therapeutic target.

Authors:  Ashok Kumar; Julie D Saba
Journal:  Expert Opin Ther Targets       Date:  2009-08       Impact factor: 6.902

7.  Genetic study between SIRT1, PPARD, PGC-1alpha genes and Alzheimer's disease.

Authors:  S Helisalmi; S Vepsäläinen; M Hiltunen; A M Koivisto; A Salminen; M Laakso; H Soininen
Journal:  J Neurol       Date:  2008-04-30       Impact factor: 4.849

Review 8.  Estrogen regulation of Dkk1 and Wnt/β-Catenin signaling in neurodegenerative disease.

Authors:  Erin L Scott; Darrell W Brann
Journal:  Brain Res       Date:  2012-12-19       Impact factor: 3.252

Review 9.  Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function.

Authors:  Montserrat Serra; Julie D Saba
Journal:  Adv Enzyme Regul       Date:  2009-11-13

10.  Genetic determinants of circulating sphingolipid concentrations in European populations.

Authors:  Andrew A Hicks; Peter P Pramstaller; Asa Johansson; Veronique Vitart; Igor Rudan; Peter Ugocsai; Yurii Aulchenko; Christopher S Franklin; Gerhard Liebisch; Jeanette Erdmann; Inger Jonasson; Irina V Zorkoltseva; Cristian Pattaro; Caroline Hayward; Aaron Isaacs; Christian Hengstenberg; Susan Campbell; Carsten Gnewuch; A Cecilej W Janssens; Anatoly V Kirichenko; Inke R König; Fabio Marroni; Ozren Polasek; Ayse Demirkan; Ivana Kolcic; Christine Schwienbacher; Wilmar Igl; Zrinka Biloglav; Jacqueline C M Witteman; Irene Pichler; Ghazal Zaboli; Tatiana I Axenovich; Annette Peters; Stefan Schreiber; H-Erich Wichmann; Heribert Schunkert; Nick Hastie; Ben A Oostra; Sarah H Wild; Thomas Meitinger; Ulf Gyllensten; Cornelia M van Duijn; James F Wilson; Alan Wright; Gerd Schmitz; Harry Campbell
Journal:  PLoS Genet       Date:  2009-10-02       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.